Pacific Biosciences of California, Inc. (PACB)
NASDAQ · Healthcare
Pacific Biosciences of California, Inc. Long Term Debt 2009–2025
Pacific Biosciences of California, Inc. annual long term debt history from 2010 to 2022. Long term debt refers to financial obligations that are due more than one year in the future.
- Pacific Biosciences of California, Inc. long term debt as of December 31, 2022: 896.7M, a 0.07% increase year-over-year.
- Pacific Biosciences of California, Inc. long term debt for 2022 were 896.7M, a 0.07% increase from 2021.
- Pacific Biosciences of California, Inc. long term debt for 2021 were 896.1M, a 5545.94% increase from 2019.
- Pacific Biosciences of California, Inc. long term debt for 2019 were 15.9M, a 8.27% increase from 2018.
- Pacific Biosciences of California, Inc. long term debt for 2018 were 14.7M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Pacific Biosciences of California, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2022 | $897 |
| 2021 | $896 |
| 2019 | $16 |
| 2018 | $15 |
| 2017 | $14 |
| 2016 | $16 |
| 2014 | $14 |
| 2013 | $13 |
| 2012 | $3 |
| 2011 | $3 |
| 2010 | $3 |
Pacific Biosciences of California, Inc. Long Term Debt — FAQ
Pacific Biosciences of California, Inc. (PACB) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PACB's long term debt history?
The chart and table above show Pacific Biosciences of California, Inc.'s long term debt by year and by quarter, including the growth rate.